Savara Pharmaceuticals
SVRA
#7027
Rank
S$0.61 B
Marketcap
$3.61
Share price
-1.84%
Change (1 day)
-46.03%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$73.92 Million a decrease over its 2022 earnings that were of -S$51.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.11 Billion48.75%
2023 -S$73.92 Million43.38%
2022 -S$51.55 Million-11.31%
2021 -S$58.13 Million-13.3%
2020 -S$67.05 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$92.86 Million105.54%
2017 -S$45.18 Million34.11%
2016 -S$33.69 Million-37.43%
2015 -S$53.84 Million38.81%
2014 -S$38.79 Million33.62%
2013 -S$29.03 Million38.49%
2012 -S$20.96 Million24.59%
2011 -S$16.83 Million-36.5%
2010 -S$26.5 Million-3.14%
2009 -S$27.36 Million-23.28%
2008 -S$35.65 Million8.52%
2007 -S$32.86 Million-34.14%
2006 -S$49.89 Million184.43%
2005 -S$17.54 Million90.75%
2004 -S$9.2 Million190.35%
2003 -S$3.17 Million11.64%
2002 -S$2.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$24.54 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA